Search results
Results from the WOW.Com Content Network
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
Ionis' application for the drug was based on data from a late-stage study in which it helped reduce triglyceride levels by 44% in patients, compared to a placebo.
IONISx is a for-profit, [2] educational technology company that offers massive open online courses (MOOCs) as well as online degrees and certifications. [3] [4] IONISx works with universities and other organizations to make some of their courses available online.
Each ICANN-accredited registrar must pay a fixed fee of US$4,000 plus a variable fee. The sum of variable registrar fees is intended to total US$3.8 million. [ 1 ] The competition created by the shared registration system enables end users to choose from many registrars offering a range of related services at varying prices.
The company developed data center and network architecture to enable internet access, becoming one of the first web hosting companies. [3] Ten years later, in 1998, 1&1 became a shareholder of Schlund+Partner. [4] In 2000, the company changed its name to United Internet and moved its product business to 1&1 Internet AG. In the same year, 1&1 ...
For premium support please call: 800-290-4726 more ways to reach us
IONIS Education Group is a private, for-profit, higher education group in France. [6] It was created in 1980 [ 7 ] and by 2023 had more than 35,000 students and 100,000 alumni. [ 8 ] There are 29 further education colleges in the group.
C. Frank Bennett is an American pharmacologist.Bennett is currently the Senior Vice President of Research and Neurology Franchise Leader at Ionis Pharmaceuticals. [1] He is a 2019 Breakthrough Prize winner in Life Sciences, which he shared with his collaborator Adrian R. Krainer for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative ...